Ironwood Pharmaceuticals (IRWD) Change in Acquisitions & Divestments (2010 - 2018)

Ironwood Pharmaceuticals (IRWD) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $19.9 million in Q4 2018.

• For the quarter ending Q4 2018, Change in Acquisitions & Divestments fell 28.48% year-over-year to $19.9 million; the trailing twelve-month figure through Dec 2018 stood at $99.2 million (down 71.41% YoY), and the FY2018 full-year result was $99.2 million, down 71.41% from the prior year.
• Change in Acquisitions & Divestments advanced to $19.9 million in Q4 2018, from $16.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $212.0 million in Q3 2015 to a low of $13.9 million in Q2 2018.
• A 5-year average of $65.0 million and a median of $48.6 million in 2018 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments surged 699.65% in 2015 and sank 89.8% in 2016, its largest moves.
• Tracing IRWD's Change in Acquisitions & Divestments over 5 years: stood at $52.5 million in 2014, then soared by 303.99% to $212.0 million in 2015, then sank by 84.23% to $33.4 million in 2016, then declined by 16.99% to $27.8 million in 2017, then dropped by 28.48% to $19.9 million in 2018.
• Business Quant data shows IRWD's Change in Acquisitions & Divestments at $19.9 million in Q4 2018, $16.8 million in Q3 2018, and $13.9 million in Q2 2018.